First-line treatment of advanced ovarian cancer: an expert update

by Branka Petrić-Miše
Published 2020-01-01

A therapeutic approach to low-grade serous ovarian carcinoma

by Branka Petrić-Miše, Dinka Šundov
Published 2020-01-01

Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study

by Ana Majić, Branka Petrić Miše, Višnja Matković, Ingrid Belac Lovasić, Kristina Katić, Ivana Canjko, Ana Frobe, Žarko Bajić, Eduard Vrdoljak
Published 2020-01-01

Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients

by Dora Čerina, Višnja Matković, Kristina Katić, Ingrid Belac Lovasić, Robert Šeparović, Ivana Canjko, Blanka Jakšić, Branka Petrić-Miše, Žarko Bajić, Marijo Boban, Eduard Vrdoljak
Published 2021-01-01